Pluton Biosciences
Unearthing world-changing solutions.
Overview
Raised: $98,000
Rolling Commitments ($USD)
06/21/2019
$636
2017
Healthcare & Pharmaceuticals
Biotech
Summary Profit and Loss Statement
FY 2018 | FY 2017 | |
---|---|---|
Revenue |
$0 |
$0 |
COGS |
$0 |
$0 |
Tax |
$0 |
$0 |
| ||
| ||
Net Income |
$-113,179 |
$0 |
Summary Balance Sheet
FY 2018 | FY 2017 | |
---|---|---|
Cash |
$46,404 |
$0 |
Accounts Receivable |
$0 |
$0 |
Total Assets |
$57,313 |
$0 |
Short-Term Debt |
$0 |
$0 |
Long-Term Debt |
$375,000 |
$0 |
Total Liabilities |
$375,000 |
$0 |
Raise History
Offering Name | Close Date | Platform | Valuation/Cap | Total Raised | Security Type | Status | Reg Type |
---|---|---|---|---|---|---|---|
Pluton Biosciences | 09/30/2021 | Self Managed | - | $6,682,968 | Equity - Common | Funded | RegD 506(b) |
Pluton Biosciences | 06/07/2019 | Nvsted | - | $98,000 | Debt | Funded | RegCF |
Pluton Biosciences | 01/02/2019 | Self Managed | - | $0 | Debt | Funded | RegD 506(c) |
Upgrade to gain access
-
$12.42 /month
billed annually - Free portfolio tracking and KingsCrowd's quantitative ratings on all raises.
- Plan Includes:
- Everything in Free, plus
- Company specific
KingsCrowd ratings (excluding risk)
- Advanced company search ( with ratings)
- Markets page filters and historical industry data
- Get Edge Annual
Edge
-
$41.58 /month
billed annually - Full site access including KingsCrowd's qualitative analyst reports.
- Plan Includes:
- Everything in Edge, plus
- Full access to detailed Analyst Reports (e.g. Top Deal, Deal to Watch, Neutral, and Underweight)
- Search and filter based on Analyst Reports
- In-depth risk ratings for every raise
- Get Edge Pro Annual